van Veelen PA - Search Results

1

ST6Gal1 targets the ectodomain of ErbB2 in a site-specific manner and regulates gastric cancer cell sensitivity to trastuzumab.

Duarte HO, Rodrigues JG, Gomes C, Hensbergen PJ, Ederveen ALH, de Ru AH, Mereiter S, Polónia A, Fernandes E, Ferreira JA, van Veelen PA, Santos LL, Wuhrer M, Gomes J, Reis CA. Duarte HO, et al. Among authors: van veelen pa. Oncogene. 2021 May;40(21):3719-3733. doi: 10.1038/s41388-021-01801-w. Epub 2021 May 4. Oncogene. 2021. PMID: 33947960 Free PMC article.

2

The gluten response in children with celiac disease is directed toward multiple gliadin and glutenin peptides.

Vader W, Kooy Y, Van Veelen P, De Ru A, Harris D, Benckhuijsen W, Peña S, Mearin L, Drijfhout JW, Koning F. Vader W, et al. Gastroenterology. 2002 Jun;122(7):1729-37. doi: 10.1053/gast.2002.33606. Gastroenterology. 2002. PMID: 12055577

3

Morphological changes during dendritic cell maturation correlate with cofilin activation and translocation to the cell membrane.

Verdijk P, van Veelen PA, de Ru AH, Hensbergen PJ, Mizuno K, Koerten HK, Koning F, Tensen CP, Mommaas AM. Verdijk P, et al. Among authors: van veelen pa. Eur J Immunol. 2004 Jan;34(1):156-64. doi: 10.1002/eji.200324241. Eur J Immunol. 2004. PMID: 14971041 Free article.

4

Proteosomal degradation of BCR/ABL protein can generate an HLA-A*0301-restricted peptide, but high-avidity T cells recognizing this leukemia-specific antigen were not demonstrated.

Posthuma EF, van Bergen CA, Kester MG, de Paus RA, van Veelen PA, de Ru AH, Drijfhout JW, Lurvink EG, Willemze R, Falkenburg JH. Posthuma EF, et al. Among authors: van veelen pa, van bergen ca. Haematologica. 2004 Sep;89(9):1062-71. Haematologica. 2004. PMID: 15377467

5

Multiple myeloma-reactive T cells recognize an activation-induced minor histocompatibility antigen encoded by the ATP-dependent interferon-responsive (ADIR) gene.

van Bergen CA, Kester MG, Jedema I, Heemskerk MH, van Luxemburg-Heijs SA, Kloosterboer FM, Marijt WA, de Ru AH, Schaafsma MR, Willemze R, van Veelen PA, Falkenburg JH. van Bergen CA, et al. Among authors: van luxemburg heijs sa, van veelen pa. Blood. 2007 May 1;109(9):4089-96. doi: 10.1182/blood-2006-08-043935. Epub 2007 Jan 18. Blood. 2007. PMID: 17234742 Free article. Clinical Trial.

6

Large-scale characterization of natural ligands explains the unique gluten-binding properties of HLA-DQ2.

Stepniak D, Wiesner M, de Ru AH, Moustakas AK, Drijfhout JW, Papadopoulos GK, van Veelen PA, Koning F. Stepniak D, et al. Among authors: van veelen pa. J Immunol. 2008 Mar 1;180(5):3268-78. doi: 10.4049/jimmunol.180.5.3268. J Immunol. 2008. PMID: 18292551

7

Dominance of an alternative CLIP sequence in the celiac disease associated HLA-DQ2 molecule.

Wiesner M, Stepniak D, de Ru AH, Moustakis AK, Drijfhout JW, Papadopoulos GK, van Veelen PA, Koning F. Wiesner M, et al. Among authors: van veelen pa. Immunogenetics. 2008 Sep;60(9):551-5. doi: 10.1007/s00251-008-0310-6. Epub 2008 Jun 27. Immunogenetics. 2008. PMID: 18584168 Free PMC article.

8

The nonpolymorphic MHC Qa-1b mediates CD8+ T cell surveillance of antigen-processing defects.

Oliveira CC, van Veelen PA, Querido B, de Ru A, Sluijter M, Laban S, Drijfhout JW, van der Burg SH, Offringa R, van Hall T. Oliveira CC, et al. Among authors: van hall t, van veelen pa, van der burg sh. J Exp Med. 2010 Jan 18;207(1):207-21. doi: 10.1084/jem.20091429. Epub 2009 Dec 28. J Exp Med. 2010. PMID: 20038604 Free PMC article.

9

HSPVdb--the Human Short Peptide Variation Database for improved mass spectrometry-based detection of polymorphic HLA-ligands.

Nijveen H, Kester MG, Hassan C, Viars A, de Ru AH, de Jager M, Falkenburg JH, Leunissen JA, van Veelen PA. Nijveen H, et al. Among authors: van veelen pa. Immunogenetics. 2011 Mar;63(3):143-53. doi: 10.1007/s00251-010-0497-1. Epub 2010 Dec 2. Immunogenetics. 2011. PMID: 21125265 Free PMC article.

10

PRAME-specific Allo-HLA-restricted T cells with potent antitumor reactivity useful for therapeutic T-cell receptor gene transfer.

Amir AL, van der Steen DM, van Loenen MM, Hagedoorn RS, de Boer R, Kester MD, de Ru AH, Lugthart GJ, van Kooten C, Hiemstra PS, Jedema I, Griffioen M, van Veelen PA, Falkenburg JH, Heemskerk MH. Amir AL, et al. Among authors: van kooten c, van veelen pa, van der steen dm, van loenen mm. Clin Cancer Res. 2011 Sep 1;17(17):5615-25. doi: 10.1158/1078-0432.CCR-11-1066. Epub 2011 Jul 19. Clin Cancer Res. 2011. PMID: 21771875

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

210 results

Search Page